CompoAtlas

ProChoice Para Aid Capsules

Natural health product licensed in Canada

Licence holder
ProChoice Herbals
NPN or DIN-HM
80063350
Status
Active licence
Licence date
13 August 2015
Revision date
12 April 2016
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Gentiana lutea

Source : Racine

75 milligrammeNot calculated
Juglans nigra

Source : Feuille

100 milligrammeNot calculated
Artemisia absinthium

Source : Feuille

100 milligrammeNot calculated
Thymus vulgaris

Source : Feuille

50 milligrammeNot calculated
Origanum vulgare

Source : Feuille

25 milligrammeNot calculated
Senna obtusifolia

Source : Feuille

50 milligrammeNot calculated
Allium sativum

Source : Bulbe

50 milligrammeNot calculated
Citrus paradisi

Source : Graine(s)

50 milligrammeNot calculated
Mentha x piperita

Source : Feuille

30 milligrammeNot calculated
Aloe vera

Source : Feuille

50 milligrammeNot calculated
Syzygium aromaticum

Source : Fleur

25 milligrammeNot calculated
Zingiber officinale

Source : Racine

50 milligrammeNot calculated

Non-medicinal ingredients

Hypromellose, Cellulose microcristalline, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Capsule2 days

Uses authorised in Canada

Text supplied in English because no French text is available.

Traditionally used in Herbal Medicine to help relieve digestive upset/disturbances including lack of appetite, nausea, digestive spasms, indigestion, dyspepsia and flatulent colic (carminative). Traditionally used in Herbal Medicine to treat intestinal parasites (vermifuge). Traditionally used in Herbal Medicine to help relieve flatulent dyspepsia and colic.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80063350

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Gentiana lutea
    Read the warning, when it applies and the studies cited

    Gentian - Gentiana Lutea

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Contraindications

    Do not use if you are pregnant (Hoffmann 2003; Morimoto et al.1983).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have stomach or duodenal acute inflammation or ulcer (Brinker 2010; ESCOP 2003; Bradley 1992).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    When using this product you may experience headaches (ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 10 January 2025

  • Thymus vulgaris
    Read the warning, when it applies and the studies cited

    THYME - THYMUS VULGARIS - Buccal

    Route of administration: Buccal (Mills and Bone 2005; Blumenthal et al. 2000)

    Cautions and warnings

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Health Canada monograph dated 28 March 2025

    THYME - THYMUS VULGARIS - Oral

    Route of administration: Oral (Mills and Bone 2005; Blumenthal et al. 2000)

    Cautions and warnings

    Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant.

    Health Canada monograph dated 26 June 2026

    THYME - THYMUS VULGARIS - Topical

    Route of administration: Topical (Mills and Bone 2005; Blumenthal et al. 2000)

    Cautions and warnings

    For external use only.

    When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.

    Contraindications

    Do not use on deep or puncture wounds, animal bites or serious burns.

    Health Canada monograph dated 28 February 2025

  • Allium sativum
    Read the warning, when it applies and the studies cited

    Garlic - Allium sativum

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Relief of upper respiratory tract infections and catarrhal (nasal congestion) conditions.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All uses.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or protease inhibitors (Brinker 2010; Mills and Bone 2005).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Brinker 2010; Mills and Bone 2005).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Mills and Bone 2005).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Brinker 2010; Mills and Bone 2005).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 January 2026

  • Mentha x piperita
    Read the warning, when it applies and the studies cited

    PEPPERMINT - MENTHA X PIPERITA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gallstones or anemia (Brinker 2010; Mills and Bone 2005; Blumenthal et al. 2000).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Essential oil.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have hiatus hernia or gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: Essential oil.

    When using this product you may experience gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Stop use if hypersensitivity/allergy occurs (Mills and Bone 2005; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 27 February 2026

  • Aloe vera
    Read the warning, when it applies and the studies cited

    ALOE VERA LEAF GEL - Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Mills and Bone 2005; Bartram 1998).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products providing 2.4 g or more fresh leaf gel, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Huseini et al. 2012; Pizzorno and Murray 2006).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Demulcent.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 28 March 2025

    ALOE - ALOE VERA/ALOE FEROX - Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney disorder or a lazy bowel (EMA 2016; Gardner and McGuffin 2013; Brinker 2010).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking heart medications, corticosteroids, diuretics, or other health products that may contribute to electrolyte imbalance (EMA 2016; Gardner and McGuffin 2013; Brinker 2010).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have inflammatory bowel disease, fever or any undiagnosed gastrointestinal trouble (EMA 2016; Gardner and McGuffin 2013; Brinker 2010).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy or diarrhea occurs (EMA 2016; Brinker 2010).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 28 March 2025

    ALOE - ALOE VERA Topical

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Gardner and McGuffin 2013; Brinker 2010).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 August 2025

  • Zingiber officinale
    Read the warning, when it applies and the studies cited

    GINGER - ZINGIBER OFFICINALE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Photograph the packaging

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2016. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line